Form 4: GoodRx Director Exercises Options, Adjusts Holdings

GoodRx Holdings Director Agnes Rey-Giraud exercised stock options and transferred shares to a family trust, adjusting her beneficial ownership.

Summary

• Agnes Rey-Giraud, a Director of GoodRx Holdings, Inc. (GDRX), exercised 192,185 stock options at an exercise price of $0.47 per share on March 12, 2026.
• Following the option exercise, she directly acquired 192,185 shares of Class A Common Stock.
• She transferred 75,219 shares of Class A Common Stock to the Agnes Rey-Giruad Trust, for which she serves as the sole trustee and sole beneficiary.
• After these transactions, her direct beneficial ownership of Class A Common Stock is 352,852 shares.
• Her indirect beneficial ownership, through the Agnes Rey-Giruad Trust, is 75,219 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction. The exercise of options by a director is generally a neutral to slightly positive signal, indicating the director is realizing value from their compensation.

Positives

• Director Agnes Rey-Giraud exercised a significant number of stock options (192,185 shares), indicating a potential belief in the company's future value at the exercise price of $0.47.
• The exercised option was fully vested and exercisable, allowing the director to realize value from her compensation.

Negatives

• The reporting of indirect ownership in Table I as "0 I" for the ARG Family Legacy Trust #1 appears inconsistent with Footnote 1, which details the transfer of 75,219 shares to a trust where the reporting person is the sole trustee and beneficiary, implying continued indirect beneficial ownership of those shares.

Future Outlook

N/A

Industry Context

StockSavvy.ai notes that insider transactions, such as option exercises, are common events for directors and executives. While this filing details a routine change in beneficial ownership, the exercise of options at a specific price can sometimes signal an insider's perspective on the company's valuation, though it is not a direct indicator of future performance.

Comparison to Industry Standards

• N/A. This Form 4 details an individual insider transaction and does not provide data for industry-wide comparisons of company performance or metrics.

Stakeholder Impact

• Shareholders: Provides transparency on director's equity holdings and transactions.
• Employees, Customers, Suppliers, Creditors: No direct impact from this filing.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the exercise of stock options and a transfer of shares to a family trust. While the option exercise indicates the director is realizing value, it does not provide new fundamental information about GoodRx Holdings, Inc.'s operational performance or strategic direction that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting further company-specific or market-wide developments.

Keywords

GoodRx Holdings, GDRX, Form 4, insider trading, stock options, beneficial ownership, director, Agnes Rey-Giraud, equity